{"id":55250,"date":"2012-11-02T06:52:40","date_gmt":"2012-11-02T06:52:40","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/research-and-markets-therapeutic-antibody-engineering-current-and-future-advances-driving-the-strongest-growth-area.php"},"modified":"2012-11-02T06:52:40","modified_gmt":"2012-11-02T06:52:40","slug":"research-and-markets-therapeutic-antibody-engineering-current-and-future-advances-driving-the-strongest-growth-area","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/research-and-markets-therapeutic-antibody-engineering-current-and-future-advances-driving-the-strongest-growth-area.php","title":{"rendered":"Research and Markets: Therapeutic Antibody Engineering: Current and Future Advances Driving the Strongest Growth Area &#8230;"},"content":{"rendered":"<p><p>    DUBLIN--(BUSINESS WIRE)--  <\/p>\n<p>    Research and Markets (<a href=\"http:\/\/www.researchandmarkets.com\/research\/kknlff\/therapeutic\" rel=\"nofollow\">http:\/\/www.researchandmarkets.com\/research\/kknlff\/therapeutic<\/a>)    has announced the addition of Woodhead Publishing Ltd's new    book \"Therapeutic antibody engineering: Current and future    advances driving the strongest growth area in the    pharmaceutical industry\" to their offering.  <\/p>\n<p>    Therapeutic Antibody Engineering examines all aspects of    engineering monoclonal antibodies and analyses the effect that    various genetic engineering approaches will have on candidates    of the future. Chapters in the first part of the book provide    an introduction to monoclonal antibodies, their discovery and    development and the fundamental technologies used in their    production. In the following chapters, the book covers a number    of specific issues relating to different aspects of antibody    engineering, including variable chain engineering, targets and    mechanisms of action, classes of antibody and the use of    antibody fragments, among many other topics. The last part of    the book examines development issues, the interaction of human    IgGs with non-human systems, and cell line development, before    a conclusion looking at future issues affecting the field of    therapeutic antibody engineering.  <\/p>\n<p>    Key Topics Covered:  <\/p>\n<p>    - Introduction to biologics and monoclonal antibodies  <\/p>\n<p>    - Value proposition for therapeutic monoclonal antibodies and    Fc fusion proteins  <\/p>\n<p>    - Antibody structure-function relationships  <\/p>\n<p>    - Fundamental technologies for antibody engineering  <\/p>\n<p>    - Sources of antibody variable chains  <\/p>\n<p>    - Variable chain engineering - humanization and optimization    approaches  <\/p>\n<\/p>\n<p>Originally posted here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/research-markets-therapeutic-antibody-engineering-114100143.html;_ylt=A2KJNTutbZNQk3cATGz_wgt.\" title=\"Research and Markets: Therapeutic Antibody Engineering: Current and Future Advances Driving the Strongest Growth Area ...\">Research and Markets: Therapeutic Antibody Engineering: Current and Future Advances Driving the Strongest Growth Area ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> DUBLIN--(BUSINESS WIRE)-- Research and Markets (<a href=\"http:\/\/www.researchandmarkets.com\/research\/kknlff\/therapeutic\" rel=\"nofollow\">http:\/\/www.researchandmarkets.com\/research\/kknlff\/therapeutic<\/a>) has announced the addition of Woodhead Publishing Ltd's new book \"Therapeutic antibody engineering: Current and future advances driving the strongest growth area in the pharmaceutical industry\" to their offering.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/research-and-markets-therapeutic-antibody-engineering-current-and-future-advances-driving-the-strongest-growth-area.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-55250","post","type-post","status-publish","format-standard","hentry","category-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/55250"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=55250"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/55250\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=55250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=55250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=55250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}